ONCOCYTE CORP (OCX) Institutional Ownership Changes & 13F Activity

ONCOCYTE CORP (OCX). Institutional ownership data tracks hedge funds, asset managers, and other institutional investors based on recent SEC Form 13F filings (Q2 2026). This page analyzes institutional buying and selling activity, new holdings, and sold-out positions in the latest reporting period. Notable filers include Broadwood Capital Inc, Pura Vida Investments, Llc, Family Office Research Llc, Vanguard Capital Management Llc, and Jane Street Group, Llc.

InstitutionTypeChange in sharesChange Position %SharesReported stock balancePortfolio quarterFiling date
Jefferies Financial Group Inc.Buy+18,10018,100$106.79KQ2 2026Aug 17, 2026
Broadwood Capital IncBuy+753,045+6.3%12,684,884$74.84MQ2 2026Aug 14, 2026
Jane Street Group, LlcBuy+157,682157,682$930.32KQ2 2026Aug 14, 2026
Awm Investment Company, Inc.Buy+30,436+1.1%2,836,692$16.74MQ2 2026Aug 14, 2026
Millennium Management LlcSell-20,971-20.3%82,499$486.74KQ2 2026Aug 14, 2026
Xtx Topco LtdSell-19,610-64.6%10,743$63.38KQ2 2026Aug 14, 2026
Osaic Holdings, Inc.Buy+15,001+62.2%39,136$230.90KQ2 2026Aug 14, 2026
Exoduspoint Capital Management, LpBuy+14,02914,029$82.77KQ2 2026Aug 14, 2026
Two Sigma Investments, LpBuy+11,10111,101$65.50KQ2 2026Aug 14, 2026
Royal Bank Of CanadaBuy+251251$1.00KQ2 2026Aug 14, 2026
Jones Financial Companies LllpBuy+6363$340.00Q2 2026Aug 14, 2026
Wells Fargo & Company/MnBuy+77$41.00Q2 2026Aug 14, 2026
Pura Vida Investments, LlcSell-462,289-48.8%484,845$2.86MQ2 2026Aug 13, 2026
Vanguard Capital Management LlcBuy+198,686+37.0%735,847$4.34MQ2 2026Aug 13, 2026
Ubs Group AgBuy+30,525+134.2%53,276$314.33KQ2 2026Aug 13, 2026
Marshall Wace, LlpBuy+16,59716,597$97.92KQ2 2026Aug 13, 2026
Vanguard Fiduciary Trust CoSell-8,015-6.0%124,576$735.00KQ2 2026Aug 13, 2026
Bnp Paribas Financial MarketsBuy+5,737+8964.1%5,801$34.23KQ2 2026Aug 13, 2026
Steward Partners Investment Advisory, LlcBuy+1,9601,960$11.56KQ2 2026Aug 13, 2026
Morgan StanleySell-573-1.6%35,515$209.54KQ2 2026Aug 13, 2026
Geode Capital Management, LlcSell-5,150-2.0%256,903$1.52MQ2 2026Aug 12, 2026
Jpmorgan Chase & CoBuy+154154$835.00Q2 2026Aug 12, 2026
Tower Research Capital Llc (Trc)Buy+2,6912,691$15.88KQ2 2026Aug 11, 2026
Cassaday & Co Wealth Management LlcSell-4-40.0%6$36.00Q2 2026Aug 10, 2026
State Street CorpBuy+41,370+81.5%92,124$543.53KQ2 2026Aug 07, 2026
Blackrock, Inc.Buy+15,176+11.2%150,521$888.07KQ2 2026Aug 07, 2026
Axq Capital, LpBuy+13,40713,407$79.10KQ2 2026Aug 06, 2026
Caitong International Asset Management Co., LtdBuy+44+4400.0%45$266.00Q2 2026Aug 05, 2026
Family Office Research LlcBuy+241,583+189.8%368,849$2.18MQ2 2026Jul 27, 2026
Fny Investment Advisers, LlcSell-64,860-26.2%182,561$1.08MQ2 2026Jul 08, 2026
Showing 30 of 44

Frequently asked questions about OCX activity

  • Which institutional owners are buying OCX?

    Institutional owners buying OCX include investors who have either initiated new positions or increased their existing holdings based on recent SEC 13F filings. The activity table above highlights which funds added shares in the latest reporting periods and how their positions changed over time.

  • What does "buy" mean in OCX activity?

    "Buy" means an investor increased their reported position in OCX compared to the prior reporting period. This reflects growing exposure to ONCOCYTE CORP (OCX) rather than necessarily a brand-new position (though new positions also appear as buys when prior quantity was zero).

  • Is institutional interest in OCX increasing?

    Institutional interest in OCX can be assessed by comparing the number of tracked funds adding or increasing positions versus those trimming or exiting across the periods shown. A higher number of additions typically signals increasing participation among large filers, but it should be read alongside position sizes and the full table.